cervical squamous cell carcinoma (Cancer)
Information
- Disease name
- cervical squamous cell carcinoma
- Disease ID
- DOID:3744
- Description
- "A cervix carcinoma that has_material_basis_in squamous cells of the cervix." [url:http\://en.wikipedia.org/wiki/Squamous-cell_carcinoma, url:http\://www.cancer.gov/dictionary?CdrID=752829]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT02020707 | Active, not recruiting | Phase 1 | Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cancers | February 24, 2014 | June 30, 2025 |
| NCT03983954 | Active, not recruiting | Phase 1 | Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumors | October 10, 2019 | October 1, 2026 |
| NCT02466971 | Active, not recruiting | Phase 3 | Testing the Addition of a New Anti-Cancer Drug, Triapine, to the Usual Chemotherapy Treatment (Cisplatin) During Radiation Therapy for Advanced-stage Cervical and Vaginal Cancers | May 10, 2016 | September 21, 2024 |
| NCT05613283 | Active, not recruiting | Primary Cervical Cancer Screening by Self-sampling HPV Test | November 19, 2022 | August 31, 2027 | |
| NCT01649089 | Active, not recruiting | N/A | Studying the Physical Function and Quality of Life Before and After Surgery in Patients With Stage I Cervical Cancer | June 5, 2013 | December 1, 2025 |
| NCT03738228 | Active, not recruiting | Phase 1 | Atezolizumab Before and/or With Chemoradiotherapy in Immune System Activation in Patients With Node Positive Stage IB2, II, IIIB, or IVA Cervical Cancer | January 7, 2019 | September 21, 2024 |
| NCT00068549 | Completed | Phase 1 | Radiation Therapy Plus Cisplatin and Gemcitabine in Treating Patients With Cervical Cancer | October 2003 | |
| NCT00104910 | Completed | Phase 1 | Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer | January 2005 | |
| NCT00217633 | Completed | Phase 2 | Pelvic Exenteration in Treating Patients With Recurrent Cervical Cancer | January 2006 | |
| NCT00309959 | Completed | Phase 2 | ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer | November 2006 | |
| NCT00389974 | Completed | Phase 2 | Sunitinib Malate in Treating Patients With Uterine Cervical Cancer That is Stage IVB, Recurrent, or Cannot Be Removed By Surgery | January 2007 | March 2009 |
| NCT00416455 | Completed | Phase 1/Phase 2 | Fludeoxyglucose (FDG) F 18 PET Scan, CT Scan, and Ferumoxtran-10 MRI Scan Before Chemotherapy and Radiation Therapy in Finding Lymph Node Metastasis in Patients With Locally Advanced Cervical Cancer or High-Risk Endometrial Cancer | September 2007 | July 16, 2016 |
| NCT00499031 | Completed | Phase 2 | Cetuximab in Treating Patients With Persistent or Recurrent Cervical Cancer | June 2007 | |
| NCT00559377 | Completed | Phase 2 | FDG and FMISO PET Hypoxia Evaluation in Cervical Cancer | November 2007 | May 2014 |
| NCT00803062 | Completed | Phase 3 | Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer | April 2009 | February 2013 |
| NCT01026792 | Completed | Phase 2 | Temsirolimus in Treating Patients With Cervical Cancer That Is Recurrent, Locally Advanced, Metastatic, or Cannot Be Removed By Surgery | December 2009 | November 2012 |
| NCT01266447 | Completed | Phase 2 | Veliparib, Topotecan Hydrochloride, and Filgrastim or Pegfilgrastim in Treating Patients With Persistent or Recurrent Cervical Cancer | February 2011 | January 2016 |
| NCT01365156 | Completed | Phase 3 | Extraperitoneal Para-aortic Lymph Node Dissection (EPLND) for Cervix | August 2011 | January 24, 2020 |
| NCT01693783 | Completed | Phase 2 | Ipilimumab in Treating Patients With Metastatic or Recurrent Human Papilloma Virus-Related Cervical Cancer | December 3, 2012 | November 24, 2021 |
| NCT01759355 | Completed | Hybrid PET/MR in the Therapy of Cervical Cancer | October 2012 | May 28, 2020 | |
| NCT01807546 | Completed | Phase 2 | Oral Rigosertib for Squamous Cell Carcinoma | March 2013 | April 2016 |
| NCT02164461 | Completed | Phase 1 | Axalimogene Filolisbac (ADXS11-001) High Dose in Women With Human Papillomavirus (HPV) + Cervical Cancer | March 4, 2015 | March 8, 2017 |
| NCT02562729 | Completed | Phase 2 | Complete Nerve-Sparing Radical Hysterectomy for Cervical Cancer | September 2015 | September 2016 |
| NCT02646319 | Completed | Early Phase 1 | Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations | January 2016 | April 24, 2018 |
| NCT00017004 | Completed | Phase 3 | Radiation Therapy and Cisplatin With or Without Epoetin Alfa in Treating Patients With Cervical Cancer and Anemia | August 2001 | |
| NCT00025233 | Completed | Phase 2 | Bevacizumab in Treating Patients With Persistent or Recurrent Cancer of the Cervix | April 2002 | July 2009 |
| NCT00031993 | Completed | Phase 2 | Erlotinib in Treating Patients With Persistent or Recurrent Cancer of the Cervix | March 2002 | |
| NCT00054444 | Completed | Phase 1 | Radiation Therapy and Chemotherapy in Treating Patients With Locally Advanced Cervical Cancer | September 2007 | |
| NCT00057863 | Completed | Phase 2 | Oxaliplatin and Paclitaxel in Treating Patients With Locally Recurrent or Metastatic Cervical Cancer | January 2003 | March 2010 |
| NCT00064077 | Completed | Phase 3 | Comparison of Four Combination Chemotherapy Regimens Using Cisplatin in Treating Patients With Stage IVB, Recurrent, or Persistent Cancer of the Cervix | May 2003 | January 30, 2018 |
| NCT04976478 | Not yet recruiting | Study of Nimotuzumab Combined With IMRT in Elder Patients With Cervical Squamous Cell Carcinoma | July 2021 | December 2026 | |
| NCT04678791 | Not yet recruiting | N/A | Nimotuzumab Combined With Chemoradiotherapy Versus Chemoradiotherapy for Local Advanced Cervical Squamous Cell Carcinoma | December 2020 | December 2025 |
| NCT06232083 | Recruiting | Phase 1/Phase 2 | Application of PLDR External Irradiation Combined With Immune Checkpoint Inhibitors in Recurrent Cervical Cancer | February 1, 2024 | February 1, 2026 |
| NCT00070317 | Terminated | N/A | Lymph Node Mapping and Sentinel Lymph Node Identification in Patients With Stage IB1 Cervical Cancer | June 2004 | January 2013 |
| NCT00262821 | Terminated | Phase 3 | Cisplatin and Radiation Therapy With or Without Tirapazamine in Treating Patients With Cervical Cancer | February 2006 | August 2010 |
| NCT05013268 | Unknown status | Phase 1 | Tislelizumab Plus TP as Neoadjuvant Therapy for Local Advanced Cervical Carcinoma | September 2021 | December 2022 |
| NCT05210348 | Unknown status | Clinical Evaluation of Detection of High Risk HPV in Urine | September 15, 2021 | May 1, 2022 |
- Disase is a (Disease Ontology)
- DOID:2893
- Cross Reference ID (Disease Ontology)
- NCI:C4028
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:254886006
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0279671
- Exact Synonym (Disease Ontology)
- squamous cell carcinoma of cervix
- Exact Synonym (Disease Ontology)
- squamous cell carcinoma of the Cervix Uteri